<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: liver transplantation</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Metabolic syndrome found in 52 percent of patients after liver transplantation</title>
   	 <description>Researchers from Israel have determined that more than half of liver transplant recipients develop post-transplantation metabolic syndrome (PTMS), placing them at greater risk for cardiovascular disease. Prior to transplantation only 5% of the patients were diagnosed with metabolic syndrome, but rates of obesity, hypertriglyceridemia, hypertension, and diabetes were significantly higher post transplantation. Full details of this retrospective-prevalence study are available in the January 2011 issue of Liver Transplantation.</description>
     <link>http://phys.org/news213530780.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 06 Jan 2011 10:06:38 EST</pubDate>
	 <guid isPermaLink="false">news213530780</guid>
	 
</item>
<item>
     <title>Study finds anti-microbials a common cause of drug-induced liver injury and failure</title>
   	 <description>New research shows that anti-microbial medications are a common cause of drug-induced liver injury (DILI) leading to acute liver failure (ALF), with women and minorities disproportionately affected. While ALF evolves slowly, once it does occur a spontaneous recovery is unlikely; however liver transplantation offers an excellent survival rate. Full findings of this ten-year prospective study are published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://phys.org/news210345029.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 30 Nov 2010 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news210345029</guid>
	 
</item>
<item>
     <title>Organ procurement air transportation displays poor safety record</title>
   	 <description>The transplant community was largely unaware of sub-standard transportation practices for donor organs until a number of fatal air crashes took the lives of transplant personnel, calling attention to procurement aviation safety. A new report highlighting the need for improved safety measures in organ procurement travel appears in the December issue of Liver Transplantation, a peer-reviewed journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news209300656.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 18 Nov 2010 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news209300656</guid>
	 
</item>
<item>
     <title>Obese children experience later mortality post liver transplantation</title>
   	 <description>A new study from the University of Washington reported obese children are at increased mortality risk in later years following primary liver transplantation (LT). Pediatric patients who are thin or severely thin, experience an early mortality risk&amp;#151;within the first year post-LT. Details of the ten-year survival analysis are published in the November issue of Liver Transplantation, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news207493188.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 Oct 2010 14:10:02 EST</pubDate>
	 <guid isPermaLink="false">news207493188</guid>
	 
</item>
<item>
     <title>Faith in God associated with improved survival after liver transplantation</title>
   	 <description>Italian researchers report that liver transplant candidates who have a strong religious connection have better post-transplant survival. This study also finds that religiosity—regardless of cause of death—prolongs the life span of individuals who underwent liver transplantation. Full findings are now available online and in the October issue of Liver Transplantation. a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news205058211.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Sep 2010 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news205058211</guid>
	 
</item>
<item>
     <title>Initial Hepatitis C drug trial complete </title>
   	 <description>The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.</description>
     <link>http://phys.org/news202626638.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Sep 2010 06:11:06 EST</pubDate>
	 <guid isPermaLink="false">news202626638</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/3dstructurei.jpg" width="90" height="90" />
</item>
<item>
     <title>Hispanics and Asians less likely to receive liver transplants</title>
   	 <description>Researchers at the University of Michigan and Arbor Research Collaborative for Health, both in Ann Arbor, have identified geographic variation as a key factor accounting for disparities in access to liver transplantation among racial and ethnic groups. Full details appear in the September issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news201433189.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Aug 2010 10:40:03 EST</pubDate>
	 <guid isPermaLink="false">news201433189</guid>
	 
</item>
<item>
     <title>Study identifies factors which predict alcohol use after liver transplantation</title>
   	 <description>Patients who receive a liver transplant due to alcoholic liver disease need to demonstrate periods of abstinence and often attend addiction treatment before transplantation. However, alcohol use disorders can recur, as can other diseases requiring transplantation, and thus alcohol use after liver transplantation is not uncommon. A new study published today in the American Journal of Transplantation reveals that those at highest risk to drink alcohol post transplant, especially in patterns that will damage their health, can be identified potentially preventing relapse.</description>
     <link>http://phys.org/news201362416.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Aug 2010 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news201362416</guid>
	 
</item>
<item>
     <title>New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment</title>
   	 <description>Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the online edition of the journal The Lancet.</description>
     <link>http://phys.org/news200234595.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 08 Aug 2010 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news200234595</guid>
	 
</item>
<item>
     <title>Placement of removable metal biliary stent in post-OLT anastomotic stricture</title>
   	 <description>Benign biliary strictures after liver transplantation are usually treated by repeated endoscopic interventions or surgery. A group of researchers in Australia reported the outcome of two patients with refractory anastomotic biliary strictures, who had successful temporary placement of a prototype removable covered self-expandable metal stent.</description>
     <link>http://phys.org/news199976441.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Aug 2010 15:00:02 EST</pubDate>
	 <guid isPermaLink="false">news199976441</guid>
	 
</item>
<item>
     <title>Vanishing bile duct syndrome secondary to anti-retroviral therapy in HIV</title>
   	 <description>Vanishing bile duct syndrome (VBDS) is an important cause of jaundice, and results from destruction of bile ducts in the liver. However, this syndrome is rare in patients with human immunodeficiency virus infection. Nevirapine, an anti-retroviral that is being increasingly used, was implicated as the cause of VBDS in a patient described in a recent report.</description>
     <link>http://phys.org/news199706046.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 30 Jul 2010 12:00:07 EST</pubDate>
	 <guid isPermaLink="false">news199706046</guid>
	 
</item>
<item>
     <title>New transplantation criteria for liver cancer patients</title>
   	 <description>Researchers at the University of California, San Francisco propose that treatments used on liver cancers beyond the established Milan criteria for liver transplantation may be appropriate for all patients with hepatocellular carcinoma (HCC) who are listed for transplantation. Full details appear in the August issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news199553785.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 28 Jul 2010 17:20:01 EST</pubDate>
	 <guid isPermaLink="false">news199553785</guid>
	 
</item>
<item>
     <title>Higher cancer rates found in liver transplant patients receiving cyclosporine for immunosuppression</title>
   	 <description>Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news196597438.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 24 Jun 2010 12:00:05 EST</pubDate>
	 <guid isPermaLink="false">news196597438</guid>
	 
</item>
<item>
     <title>Researchers develop functional, transplantable rat liver grafts</title>
   	 <description>A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital (MGH) has developed a technique that someday may allow growth of transplantable replacement livers.  In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.</description>
     <link>http://phys.org/news195645553.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 13 Jun 2010 13:00:08 EST</pubDate>
	 <guid isPermaLink="false">news195645553</guid>
	 
</item>
<item>
     <title>Commonly used seizure drug could treat severe genetic liver disease: study</title>
   	 <description>The liver scarring of [alpha]1-antitrypsin (AT) deficiency, the most common genetic cause for which children undergo liver transplantation, might be reversed or prevented with a medication that has long been used to treat seizures, according to findings from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine that will published in Science and are available online today through the Science Express website.</description>
     <link>http://phys.org/news194793999.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 03 Jun 2010 14:27:46 EST</pubDate>
	 <guid isPermaLink="false">news194793999</guid>
	 
</item>
<item>
     <title>Antiviral therapy during compensated cirrhosis most cost-effective approach</title>
   	 <description>Researchers at the UCLA Medical Center found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C (HCV) infection. Full details appear in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news194179638.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 27 May 2010 12:10:03 EST</pubDate>
	 <guid isPermaLink="false">news194179638</guid>
	 
</item>
<item>
     <title>Trials begin on potent new hepatitis C drug</title>
   	 <description>The first clinical trials have started on a new investigational drug, discovered by researchers at Cardiff University, which is being  developed to treat infections caused by Hepatitis C virus.</description>
     <link>http://phys.org/news193051473.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 14 May 2010 10:24:53 EST</pubDate>
	 <guid isPermaLink="false">news193051473</guid>
	 
</item>
<item>
     <title>Molecular adsorbent recirculating system treatment for acute liver failure</title>
   	 <description>The molecular adsorbent recirculating system (MARS) is used in the treatment of liver failure patients to enable either native liver recovery or as a bridging treatment to liver transplantation. A recent study from Finland suggests that MARS treatment is both less costly and more effective than standard medical therapy in acute liver failure patients.</description>
     <link>http://phys.org/news192876736.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 12 May 2010 10:10:04 EST</pubDate>
	 <guid isPermaLink="false">news192876736</guid>
	 
</item>
<item>
     <title>Study shows liver transplant center impacts patient outcomes</title>
   	 <description>For patients in need of a liver transplant, their choice of a transplant center can make a noteworthy difference in their outcomes, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego.</description>
     <link>http://phys.org/news192083460.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 May 2010 06:40:02 EST</pubDate>
	 <guid isPermaLink="false">news192083460</guid>
	 
</item>
<item>
     <title>Lung cancer risk particularly high for heart and liver transplant recipients</title>
   	 <description>Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.</description>
     <link>http://phys.org/news191926394.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 01 May 2010 09:53:25 EST</pubDate>
	 <guid isPermaLink="false">news191926394</guid>
	 
</item>
<item>
     <title>Study links liver transplantation to accelerated cellular aging</title>
   	 <description>Researchers at the University of Cambridge found that liver transplant recipients develop premature immune senescence, the normal process by which the immune system ages and becomes less effective. Full details appear in the May issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news191752978.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 29 Apr 2010 09:44:34 EST</pubDate>
	 <guid isPermaLink="false">news191752978</guid>
	 
</item>
<item>
     <title>New treatment cures baby of often-fatal metabolic disorder</title>
   	 <description>(PhysOrg.com) -- Physicians at Packard Children's Hospital believe they are the first to cure an infant of a serious disorder using prenatal infusions followed by liver transplant after his birth.</description>
     <link>http://phys.org/news191512703.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 26 Apr 2010 15:20:04 EST</pubDate>
	 <guid isPermaLink="false">news191512703</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/3-newtreatment.jpg" width="90" height="90" />
</item>
<item>
     <title>Blood test enables heart-transplant recipients to undergo fewer biopsies, study shows</title>
   	 <description>After his heart transplant in 2005, Ramon Llenado underwent a biopsy every week, then every month, then every three months. Most heart transplant patients face a lifetime of these invasive tests, which involve snipping out tiny pieces of heart to check for possible organ rejection.</description>
     <link>http://phys.org/news191069089.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 22 Apr 2010 10:00:02 EST</pubDate>
	 <guid isPermaLink="false">news191069089</guid>
	 
</item>
<item>
     <title>Researchers identify new gene involved in the development of liver cancer</title>
   	 <description>Virginia Commonwealth University researchers have identified a new tumor-promoting gene that may play a key role in the development of liver cancer. Levels of the gene's expression are significantly higher in more than 90 percent of patients with the disease compared to their healthy counterparts.</description>
     <link>http://phys.org/news190913891.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 19 Apr 2010 16:39:04 EST</pubDate>
	 <guid isPermaLink="false">news190913891</guid>
	 
</item>
<item>
     <title>New studies help establish potential of artificial liver support devices</title>
   	 <description>Results from two studies presented today at the International Liver Congress 2010 have shown that treatment with extracorporeal devices may not confer a survival advantage for severe liver failure patients, despite positive dialysis effects. However, results among a small sub-group of patients show promise.</description>
     <link>http://phys.org/news190632132.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 16 Apr 2010 12:30:04 EST</pubDate>
	 <guid isPermaLink="false">news190632132</guid>
	 
</item>
<item>
     <title>New insights into treatment options for patients suffering from severe alcoholic hepatitis</title>
   	 <description>Results from two French studies presented today at the International Liver Congress 2010 press conference will help inform clinical practice in the treatment of patients with severe or acute alcoholic hepatitis.</description>
     <link>http://phys.org/news190631367.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 16 Apr 2010 10:30:01 EST</pubDate>
	 <guid isPermaLink="false">news190631367</guid>
	 
</item>
<item>
     <title>Living donor exchange poses new option for liver transplantation</title>
   	 <description>Two major transplant centers in Hong Kong and South Korea released results from their paired donor exchange programs for living donor liver transplantation (LDLT).  A single paired exchange, performed by the Hong Kong team under emergency circumstances, was a success.  The Korean team reported 16 donor exchanges conducted over a 6-year period were successful. Full details of this novel approach to organ transplantation appear in the April issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news189338525.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 01 Apr 2010 11:02:28 EST</pubDate>
	 <guid isPermaLink="false">news189338525</guid>
	 
</item>
<item>
     <title>Researchers identify potential new target for treating hepatitis C</title>
   	 <description>A team of scientists including University of Utah researchers has discovered that binding of a potent inhibitor of the hepatitis C virus (HCV) to the genetic material of the virus causes a major conformational change that may adversely affect the ability of the virus to replicate. This discovery, published in the March 29 early edition of the Proceedings of the National Academy of Sciences, provides a potential new target for structure-based design of new hepatitis C treatments.</description>
     <link>http://phys.org/news189086790.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 29 Mar 2010 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news189086790</guid>
	 
</item>
<item>
     <title>New therapies increase survival rates in post-transplant liver cancer patients</title>
   	 <description>A recent study found that sirolimus-based immunosuppression following liver transplantation in patients with non-resectable hepatocellular carcinoma (liver cancer) significantly increases survival rates for this patient population.  Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://phys.org/news188731529.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 25 Mar 2010 10:25:46 EST</pubDate>
	 <guid isPermaLink="false">news188731529</guid>
	 
</item>
<item>
     <title>Beyond liver transplants: Acutely damaged livers may be repaired via transplanted hepatocytes</title>
   	 <description>A research team from the National Taiwan University Hospital has evaluated the efficiency of transplanted hepatocyte (liver) cells in animal models severely damaged by two kinds of chemical toxicity to see whether and how transplanted hepatocytes were able to efficiently repopulate the toxin-induced, severely damaged livers.</description>
     <link>http://phys.org/news184254407.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Feb 2010 15:20:01 EST</pubDate>
	 <guid isPermaLink="false">news184254407</guid>
	 
</item>


</channel>
</rss>
